Finding the best prices at pharmacies near you...

Prescription & Medication Blog

At ModRN Health we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that ModRN Health provides, the ModRN Health Blog is here to bring you information, news, current events, and important updates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!


A new hepatitis C virus (HCV) treatment is expected to appear in pharmacies soon following US Food and Drug Administration's (FDA) decision to approve Vosevi, an HCV treatment developed by Gilead Sciences, Inc. The drug was cleared to treat adults with chronic HCV genotypes 1-6 with no cirrhosis,...

Read More... Jul 20, 2017

The rate of medication errors among US residents has increased by more than 100 percent in recent years, according to a study conducted by The Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children’s Hospital and published in Clinical Toxicology. The...

Read More... Jul 19, 2017

Sporting injuries or those caused during physical activity and exercise are among the most common in the US, particularly among the nation's children. Figures from the National SAFE KIDS Campaign and American Academy of Pediatrics suggest around 3.5 million sporting injuries are suffered by kids...

Read More... Jul 17, 2017

The World Health Organization (WHO) has warned antibiotic resistance is making gonorrhea harder to treat, suggesting a heightened need to develop new antibiotics. It brought together data from 77 countries around the world, which revealed the common sexually transmitted disease (STD) is...

Read More... Jul 15, 2017

Novo Nordisk has announced a recall of six batches of the insulin cartridge holders used in its NovoPen Echos due to the possibility they will crack or break when exposed to certain chemicals. The company revealed some cleaning agents may contain agents that could leave the device susceptible to...

Read More... Jul 14, 2017

The US Food and Drug Administration (FDA) has unveiled a 90-day plan to address the backlog of around 200 orphan drug designation requests that have been pending for more than 120 days. The regulatory body aims to complete reviews of all requests in this category by September 21st 2017 and plans to...

Read More... Jul 05, 2017

A new once-daily medication to treat patients with attention deficit and hyperactivity disorder (ADHD) aged 13 and above has been approved by the US Food and Drug Administration (FDA). Shire first filed an application to market the drug in US pharmacies in 2006, but was required to conduct...

Read More... Jul 03, 2017

Keeping up to date with vaccinations and immunization records plays an important role in staying one step ahead of infectious diseases. It is particularly important in children and infants, with modern vaccines providing protection against a number of illnesses that can prove dangerous and...

Read More... Jun 21, 2017

A cheaper alternative to the EpiPen will soon be available in pharmacies for patients suffering from severe allergies. The US Food and Drug Administration (FDA) approved a new epinephrine pre-filled syringe (PFS) called Symjepi, which is manufactured Adamis Pharmaceuticals...

Read More... Jun 19, 2017

Over-the-counter (OTC) medication offers quick and convenient relief for a whole range of symptoms, conditions and ailments, but with a bewildering variety of products available in pharmacies and drugstores, making an informed decision about OTC medicine can be a challenge for consumers. Should you...

Read More... Jun 16, 2017

The US Food & Drug Administration (FDA) has approved the first generic version of Truvada (emitricitabine/tenofovir disoproxil fumarate), a medication used in the treatment and prevention of HIV infection. Gilead Science's branded drug Truvada is a combination of the antiretroviral drugs...

Read More... Jun 15, 2017

Pharmaceutical firm Bristol-Myers Squibb has announced a voluntary recall of one lot of Eliquis (apixaban) 5mg tablets following a consumer complaint that their bottle contained 2.5mg tablets. The affected lot is a 60-count bottle containing 5mg tablets of the medication and it was distributed...

Read More... Jun 14, 2017